Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary R Sia

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|August 14, 2020
Engineered Nanoparticle Applications for Recombinant Influenza VaccinesZachary R Sia, Matthew S Miller, Jonathan F Lovell
Bio-Protocol|April 13, 2026
Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine DevelopmentZachary R Sia, Wei-Chiao Huang, Matthew Willadsen, et al.
Journal of Virology|September 15, 2022
Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza VirusZachary R Sia, Kevin Chiem, Wei-Chiao Huang, et al.
Cell Reports. Medicine|February 24, 2024
Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccineZachary R Sia, Jayishnu Roy, Wei-Chiao Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challengeZachary R Sia, Xuedan He, Ali Zhang, et al.
Science Advances|June 26, 2026
A subunit vaccine for multiple respiratory virusesQinzhe Li, Wei-Chiao Huang, Sara H Mahmoud, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|August 14, 2020
Engineered Nanoparticle Applications for Recombinant Influenza VaccinesZachary R Sia, Matthew S Miller, Jonathan F Lovell
Bio-Protocol|April 13, 2026
Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine DevelopmentZachary R Sia, Wei-Chiao Huang, Matthew Willadsen, et al.
Journal of Virology|September 15, 2022
Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza VirusZachary R Sia, Kevin Chiem, Wei-Chiao Huang, et al.
Cell Reports. Medicine|February 24, 2024
Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccineZachary R Sia, Jayishnu Roy, Wei-Chiao Huang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
A liposome-displayed hemagglutinin vaccine platform protects mice and ferrets from heterologous influenza virus challengeZachary R Sia, Xuedan He, Ali Zhang, et al.
Science Advances|June 26, 2026
A subunit vaccine for multiple respiratory virusesQinzhe Li, Wei-Chiao Huang, Sara H Mahmoud, et al.
Pageof 1